Product Information
PINDOLOL 5 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.5969 per EA under NDC 62559056001. Its NADAC has been published 478 times since Jul 5, 2017.
FDA first approved this application on Mar 29, 1993. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559056001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PINDOLOLApproval Type
Generic (ANDA)
FDA Application
ANDA073609FDA Approved
3/29/1993
TE Code
AB
On Market Since
5/8/2017
Pharmacological Classes
Price Statistics
The NADAC for PINDOLOL 5 MG TABLET has been published 478 times since Jul 5, 2017, and over the history we have for it it has declined 26.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5969 per EA |
|---|---|
| All-time high | $0.9064 (Dec 15, 2021) |
| All-time low | $0.3653 (May 22, 2024) |
| 52-week high | $0.7057 |
| 52-week low | $0.5224 |
| Median price | $0.7483 |
| Average price | $0.7288 |
| Largest weekly change | +57.9% (Jun 19, 2019) |
| Weeks tracked | 478 |
| Tracking since | Jul 5, 2017 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Pindolol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PINDOLOL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PINDOLOL 5 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.5969 per EA (NDC 62559056001), effective Sep 30, 2026.
How has the price of PINDOLOL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PINDOLOL 5 MG TABLET has declined 26.2%. It has been tracked across 478 weekly CMS publications since Jul 5, 2017.
What are the highest and lowest recorded NADAC prices for PINDOLOL 5 MG TABLET?
Since Jul 5, 2017, the NADAC for PINDOLOL 5 MG TABLET has ranged from a low of $0.3653 (May 22, 2024) to a high of $0.9064 (Dec 15, 2021), with a median of $0.7483 per EA.
Are there cheaper alternatives to PINDOLOL 5 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PINDOLOL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PINDOLOL 5 MG TABLET?
PINDOLOL 5 MG TABLET (NDC 62559056001) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.